kth.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nanocarriers for Inner Ear Disease Therapy
Wuhan Univ, Zhongnan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Wuhan, Peoples R China.;Dawu Cty Peoples Hosp, Dept Otorhinolaryngol, Xiaogan, Peoples R China..
Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Biliary Pancreat Surg, Wuhan, Peoples R China..
Dawu Cty Peoples Hosp, Dept Otorhinolaryngol, Xiaogan, Peoples R China..
Wuhan Univ, Zhongnan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Wuhan, Peoples R China..
Show others and affiliations
2021 (English)In: Frontiers in Cellular Neuroscience, E-ISSN 1662-5102, Vol. 15, article id 791573Article, review/survey (Refereed) Published
Abstract [en]

Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy.

Place, publisher, year, edition, pages
Frontiers Media SA , 2021. Vol. 15, article id 791573
Keywords [en]
nanocarrier, drug delivery system, inner ear disease therapy, soft material nanoparticle, inorganic nanoparticle
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:kth:diva-306766DOI: 10.3389/fncel.2021.791573ISI: 000731018200001PubMedID: 34924960Scopus ID: 2-s2.0-85121379067OAI: oai:DiVA.org:kth-306766DiVA, id: diva2:1623785
Note

QC 20211230

Available from: 2021-12-30 Created: 2021-12-30 Last updated: 2023-02-22Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Zhou, Yuye

Search in DiVA

By author/editor
Zhou, Yuye
By organisation
Applied Physical Chemistry
In the same journal
Frontiers in Cellular Neuroscience
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf